Literature DB >> 8520765

Rapid diagnosis of pleural tuberculosis by polymerase chain reaction.

J M Querol1, J Mínguez, E García-Sánchez, M A Farga, C Gimeno, J García-de-Lomas.   

Abstract

We have investigated the use of polymerase chain reaction (PCR) for the rapid diagnosis of pleural tuberculosis. The study was composed of 21 patients with pleural tuberculosis, confirmed by culture or pleural biopsy, and 86 control subjects. The PCR assay was based on detecting a 123-bp DNA segment belonging to the insertion sequence IS6110, specific of Mycobacterium tuberculosis complex. In 21 patients diagnosed with pleural tuberculosis, Ziehl-Neelsen staining was positive in three (14%) (95% CI, 7 to 21%) and pleural fluid culture in 11 (52%) (95% CI, 43 to 61%). Pleural biopsy revealed granulomas with caseous necrosis in 72%, and the culture was positive in 67% of the patients. Adenosine deaminase activity determination was positive (> 45 IU/L) in 86% (95% CI, 79 to 93%). The sensitivity and specificity for PCR was 81% (95% CI, 74 to 88%) and 100% (95% CI, 95 to 100%), respectively. All culture-positive specimens were PCR positive. We conclude that PCR is a rapid, sensitive, and specific method for the diagnosis of pleural tuberculosis. However, further prospective studies are required to properly evaluate the yield of the technique.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8520765     DOI: 10.1164/ajrccm.152.6.8520765

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  10 in total

Review 1.  Relevance of commercial amplification methods for direct detection of Mycobacterium tuberculosis complex in clinical samples.

Authors:  Claudio Piersimoni; Claudio Scarparo
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

2.  Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis.

Authors:  V C C Cheng; W C Yam; I F N Hung; P C Y Woo; S K P Lau; B S F Tang; K Y Yuen
Journal:  J Clin Pathol       Date:  2004-03       Impact factor: 3.411

Review 3.  Molecular diagnostics in tuberculosis.

Authors:  V C C Cheng; W W Yew; K Y Yuen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

4.  Diagnosis of extrapulmonary tuberculosis by smear, culture, and PCR using universal sample processing technology.

Authors:  Soumitesh Chakravorty; Manas Kamal Sen; Jaya Sivaswami Tyagi
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  Rapid diagnosis of extrapulmonary tuberculosis by PCR: impact of sample preparation and DNA extraction.

Authors:  S Honoré-Bouakline; J P Vincensini; V Giacuzzo; P H Lagrange; J L Herrmann
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 6.  Molecular diagnostics in tuberculosis: basis and implications for therapy.

Authors:  Seetha V Balasingham; Tonje Davidsen; Irena Szpinda; Stephan A Frye; Tone Tønjum
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

7.  Evaluation of polymerase chain reaction for rapid diagnosis of clinically suspected tuberculous pleurisy.

Authors:  Dinesh Sharma; G N Dhobi; Sonaullah Shah; Rafiqa Eachkoti; Ishraq Hussain; Zafar A Shah; Mushtaq A Siddiqi
Journal:  Indian J Clin Biochem       Date:  2006-09

8.  Improved diagnosis of pleural tuberculosis using the microscopic- observation drug-susceptibility technique.

Authors:  Marco Tovar; Mark J Siedner; Robert H Gilman; Carlos Santillan; Luz Caviedes; Teresa Valencia; Oswaldo Jave; A Rod Escombe; David A J Moore; Carlton A Evans
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

Review 9.  Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology).

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

Review 10.  Nucleic acid amplification tests in the diagnosis of tuberculous pleuritis: a systematic review and meta-analysis.

Authors:  Madhukar Pai; Laura L Flores; Alan Hubbard; Lee W Riley; John M Colford
Journal:  BMC Infect Dis       Date:  2004-02-23       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.